Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-23

FDA Approved: MYCOPHENOLIC ACID — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved the original application for generic mycophenolic acid by Ascend Laboratories, authorizing its use to prevent organ transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolic acid (mycophenolic acid)

Snippet

ORIG AP for MYCOPHENOLIC ACID (MYCOPHENOLIC ACID)